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Summary.-The cytolysis of 3H-proline-labelled tumour cells growing in monolayer
by syngeneic immune lymphocytes has been studied in the murine sarcoma virus
(MSV) system. Results show that the proline assay (PA) is a convenient way to reveal
the activity of cytolytic T lymphocytes against FMR-like antigens. Using the same
effector and target cells, the classical chromium-release test (CRT) fails to reveal
any cytolytic activity, and the visual microcytotoxicity assay as well as several
derived isotopic methods are known to reveal mainly non-specific reactions due to
non-T effector cells. The PA, therefore, appears to be a useful method for testing an
antitumour reaction against tumour cells in monolayer. The results are, however,
different from those obtained in the CRT using the same effector cells but lymphoma
cells in suspension as targets, the major discrepancies being the following: (a) the
PA does not provide truly quantitative data, due to the very high lymphoid: effector
cell ratios needed in this test; (b) unexpected patterns of antigenic specificities are
sometimes detected in PA; (c) a non-specific natural killer activity of non-T cells is
frequently detected in the PA, masking at low lymphoid : target cell ratios the
T-dependent specific cytolysis; (d) the H-2 restriction of the cytolytic T-cell
activity is poorly detected in PA, whereas the role of H-2 antigens is clearly shown
by blocking experiments using anti-H-2 antibodies.
ONE of the major problems facing
tumour immunologists studying cell-
mediated reactions results from the dis-
parity in the results with different in vitro
cytotoxicity assays. Such disparity could
be caused by variations in methodological
parameters, which include the nature of
the target cells and the length of the
incubation period in vitro with the effector
cells. Both the original visual microcyto-
toxicity assay (MA) (Takasugi & Klein,
1970) and several derived radioisotopic
methods (Jagarlamoody et al., 1971;
Cohen et al., 1972; Hashimoto & Sudo,
1971; Perlmann & Holm, 1969; Hashi-
moto et al., 1969; Bean et al., 1973) require
long incubation periods and target cells in
monolayers. Most of them reveal simul-
taneously cytostatic and cytolytic activi-
ties due to different effector cell popula-
tions, including T and non-T cells as it has
been shown, for example, in the murine
sarcoma virus (MSV) system (Lamon et al.,
1973; Plata et al., 1974; Owen & Seeger,
1973). The cytostatic phenomenon
mediated by non-T cells being, at least for
the main part, non-specific (Owen &
Seeger, 1973; Senik et al., 1974) it is often
difficult to assess the specificity of the
reactions measured by such methods.
More antigen-specific reactions are
generally obtained using short-term assays
with ascitic lymphoma cells or tumour
cells cultivated in suspension as targets.
Under these conditions, very clear results
can be obtained in the MSV system,
regardless of the isotopic marker e.g., 51Cr
(Leclerc et al., 1972), 125IUdR (Oldham
& Herberman, 1973) or 3H-proline (Shiku
et al., 1975; Oldham et al., 1977). These
tests appear especially valuable in reveal-
ing the activity ofcytolytic T lymphocytesY. HENIN, E. GOMARD, S. GISSELBRECHT AND J. P. LEVY
(CTL). They are, however, much less
efficient with target cells in monolayers.
Relatively few in vitro-maintained tumour
cells being available in suspension, only a
limited number of tumour antigens can,
therefore, be studied under optimal con-
ditions. The availability of a specific
cytotoxic assay using target cells in
monolayers but revealing only cytolytic
reactions would, therefore, constitute
a major advance in tumour immuno-
logy.
The proline assay (PA) was initially
proposed (Bean et al., 1973) because:
(1) 3H-proline is retained by the target
cells longer than 51Cr or 3H-thymidine;
(2) it is less toxic than 125IUdR or [3H]-
TdR; (3) when released by destroyed
target cells the label is not re-utilized,
because cold proline is present in large
excess in the medium; (4) the results are
not noticeably affected by proliferation or
cytostasis of tumour cells during the
incubation, so that only cytolysis is
measured. This method appeared, there-
fore, as a candidate to replace other tests
in the study of target cells in monolayers.
It has notably been applied in the study
of chemically induced sarcomas (Shiku et
al., 1975) and the MSV tumour (Weiland
& Mussgay, 1976). Here we report results
of experiments using the latter system,
aimed at determining the nature of
effector cells, the level ofH-2 restriction of
target-cell cytolysis and the antigenic
specificities involved. The results show on
the one hand that the PA clearly reveals
CTL-mediated reactions but, on the other
hand, that the results obtained are not
identical with those found using the Cr-
release test (CRT). Themajordiscrepancies
concern the frequent detection of non-T-
cell-mediated cytolysis, the lower precision
in the quantification of the reactions, the
less clear H-2 restriction of the CTL
activity, and the unexpected lack of
activity of some effector-cell populations.
This suggests that some caution is neces-
sary in the interpretation of antitumour
reactions measured using PA, further
emphasizing the difficulty in comparing
antitumour cell-mediated reactions in
different assays.
MATERIALS AND METHODS
Mice.-One to 2-months old C57BL/6 (B6)
BALB/B, B10.D2 and BALB/c mice were
raised in our own colonies.
Viruses.-Tumours were induced in vivo,
either by MSV-Moloney isolate, (maintained
in vivo by regular acellular passages in new-
born B6) or by the Friend leukaemia virus
(FLV) (maintained in vivo in adult BALB/c).
To infect cultured cells in vitro, the same
agents or in vitro-produced viruses were used.
The Moloney leukemia virus (MLV) was
harvested from the supernatant of virus-
infected non-Fv.1-restricted 3T3.FL lines,
initially derived from NIH Swiss embryos.
The Gross leukaemia virus (GLV) was simi-
larly obtained from an in vitro-infected SCI
line derived from wild mice, the Rauscher
leukaemia virus (RLV) from a BALB/c 3T3
line in vitro transformed by a RLV pseudo-
type ofMSV.
Cell lines.-Their main characteristics are
summarized in Table I.
Immune lymphocytes.-Anti-MSV immune
lymphocytes were harvested from the spleens
of adult mice inoculated 10-15 days before
with 0-2 ml of a 10-1 dilution of the virus.
Anti-FLV immune lymphocytes were ob-
tained similarly from the spleen of adult B6,
10-20 days after an 0-1 ml i.p. inoculation of
1/5 diluted FLV. Spleen-cell pellets were
incubated 20 secindistilled waterto eliminate
red blood cells and the normal osmolarity was
then adjusted by adding hypertonic NaCl.
The cells were washed in medium and their
concentration adjusted to the test density.
Normal spleen cells from the same inbred
strain of mice were used as controls.
Effector-cellpurification.-(1) T cell elimina-
tion. Non-T cells were purified by eliminating
Thy-1-2 cells from the whole-spleen cell sus-
pensions using AKR anti-Thy-1-2 serum and
rabbit complement. The preparation and
specificity ofthe anti-Thy-1-2 serum, and the
technical conditions used have been de-
scribed previously (Leclerc et al., 1973).
(2) T-cell enrichment. T cells were enriched
by passing the whole-spleen cell suspensions
through nylon-wool columns (Julius et al.,
1973). Columns were first incubated for 1 h
at 370C with 25 ml of medium supplemented
with foetal calf serum (FCS). After washing,
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TABLE I.-Target cells
Cell lines
MSB
MSC
B6 MEF
NZB, clone S-2
SWISS 3T3
BALB 3T3
C3H
C3H Moloney
K-BALB
K-BALB-Moloney
MSV-85
SC-1
CCC S+L-
NRK
Reference
Pearson et al., 1973
Massicot et al., 1971
Our laboratory
Levy, 1973
Todaro & Green, 1963
Aaronson & Todaro, 1968
Reznikoff et al., 1973
Our laboratory
Aaronson & Weaver, 1971
Our laboratory
Aaronson & Rowe, 1970
Hartley & Rowe, 1975
Fischinger et al., 1974
Duc-Nguyen et al., 1966
Virus produced
M-MSV(MLV)
M-MSV(MLV)
None
Xenotropic
None
None
None
MLV
None
Ki-MSV(MLV)
None
None
Xenotropic RD-114
None
t MSV Moloney isolate.
t MSV Kirsten isolate.
§ HT-1 isolate of the M-MSV.
2 x 108 lymphocytes in 2 ml of FCS-supple-
mented medium were added, and 30 min later
they were passed at a rate of 1 ml/min.
(3) Macrophage elimination. Macrophages
were removed from unfractionated spleen-cell
suspensions by: (a) carbonyl iron and magnet
treatment; (b) plastic culture-flask adherence
at 3700 for 1 h (Golstein & Blomgren, 1973);
(c) successive treatment by both methods.
The 3H-proline assay (PA).-PA was per-
formed using a slightly modified version of
the original method of Bean et al., (1973).
Target-cell monolayers at 80% confluence in
T-30 flasks were washed twice with minimum
Eagle's medium (MEM) lacking non-essential
amino acids (including proline) and incubated
overnight in MEM lacking non-essential
amino acids plus 15% FCS at 370C in a 5%
C02 atmosphere, in the presence of 100 ,tCi
3H-proline (L-proline 3H-5, sp. act.: 22
Ci/mmol, CEA, Gif sur Yvette, France). The
following day the culture was washed twice
with complete MEM containing 15% FCS
and 2% non-essential amino acids and incu-
bated for 20-30 min at 37°0. The cells were
detached with 0.05% trypsin, centrifuged
10 min at 800g, suspended in 1 ml MEM con-
taining 10% FCS and 1% non-essential amino
acids (test medium), and the cell concentra-
tion adjusted to 105 cells/ml. Ten ,ul contain-
ing 1000 target cells were distributed with a
microlitre syringe into the wells of microtest
II plates prefilled with 0-1 ml oftest medium.
Effector cells were added -4 h later in 0-1 ml
of test medium, the lymphoid target cell
(L/T) ratios varying from 25:1 to 300:1. Six
to 8 replicates were used for each L/T ratio.
After 24-48 h incubation at 37°C under 5%
C02, the plates were inverted, shaken slightly
to remove medium, then submerged X3 in
prewarmed PBS containing 10% FCS, and
wiped with blotting paper. The cells remain-
ing alive were harvested by adding 250 ,ul of
0.05% trypsin to each well, and transferred to
scintillation vials. The arithmetic mean of6-8
wells was calculated in order to estimate
percentage relative inhibition of tumour cells
after incubation with normal or immune
lymphocytes, this inhibition being expressed
as follows:
inhibition=100 x
(mean ct/min after incubation i
with normal lymphocytes J
(mean ct/min after incubationi
with immune lymphocytes J
mean ct/min after incubation
with normal lymphocytes
The activity of the effector-cell suspension
was also expressed in lytic units per 106
effector cells (LU) as previously reported
(Plata et al., 1975): one LU represents the
number of effector cells necessary to decrease
by 50% the radioactivity of 1000 target cells.
All statistical analyses were performed using
Student's t test. The levels of significance
were expressed as usual: NS=not significant,
*=0.05>P>0.01, **=0.01>P>0 001,
*** =P<0.001.
The 51Cr-release test (CRT) was performed
as previously described (Leclerc et al., 1972)
Transforming
agent
M-MSVt
M-MSV
None
None
None
None
None
None
Ki-MSVt
Ki-MSV
HT-1-MSV§
None
None
None
Origin
C57BL/6
BALB/c
C57BL/6
NZB
Non-inbred
Swiss
BALB/c
C3H/He
C3H/He
BALB/c
BALB/c
BALB/c
Wild mouse
Cat
Rat
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using as target cells the B6 Molon
induced MBL2 lymphoma cells.
Blocking of the cytolysis by antiser
target cells in 10 ,ul of medium c(
10% FCS and 1% non-essential am
were incubated for 2 h at 37°C in 5'
the presence of0 1 ml ofnormal inact
immune serum diluted 1: 2 or mediu
The sera were then removed using E
pipette, and 3 x 105 effector cells
were added to each well. After 24 h
activity was calculated by compe
cytolysis of target cells in the pr
normal or immune serum.
RESULTS
Levels and specificity of the a'
reactions detected in PA
The spleen cells of MSV re
harvested at the beginning of
rejection some 12-16 days aft
inoculation, were always effectiv
against MSV tumour cells, whe
L/T ratios were used (Table I:
decreasing ratios, lower levels of i
activity were detected. When ali
TABLE III.-Cytolytic activity o
infected B6 mouse spleen cells a,,
by 3 different assays
% reduction of target-(
radioactivity
Spleen cell:
target cell
ratio
Expt 1
200:1
100:1
50:1
20:1
Expt 2
200:1
100:1
50:1
20:1
CRT
with MBL2
target
cellst
45-611
43 0
22-4
13-3
59-8
57-5
23-2
17-2
CRT
with MSB
target
cellsl
Oil
0
0
0
0
0
0
((a) incubated overnil
t 10,000 per medium.
well. (b) labelled in situ
5000 per 5 tCi oft51Cr for 1
well. (c) after washing, effi
were added to eacl
§ 1000 MSB per well
Calculated as described in Materials ar
after 18 h incubation with the 3 assa
Ley-virus-
ra.-1000
ontaining
ino acids
%/ CO2 in
tivated or
am alone.
a Pasteur
in 01 ml
the final
Lring the
esence of
nti-MSV
the same effector and target-cell prepara-
tions were tested in CRT, no activity was
found (Table III). Nevertheless, the same
effector-cell preparations were always
highly efficient in CRT against MBL2
lymphoma cells in suspension. The maxi-
mum cytolytic activity detected against
MSV tumour cells in monolayer (PA) or
against the antigenically related MBL2
cells in suspension (ORT) were in the same
range, but when different L/T ratios were
used in both tests it appeared that, in
terms of LU/106 effector cells, CRT was
more sensitive than PA. However, the
latter method was able to show cytolysis
ofMSV tumour cells, which CRT failed to
detect.
A good level of cytolysis was also found
gressors, in PA when normal mouse embryonic
tum.our fibroblasts (MEF) infected in vitro with
re in PA differenttransforming ornon-transforming
type C viruses, were used as target cells n 300: 1 (Table IV). MLV, FLV or RLV-infected L). With cells were regularly lysed, whereas normal cytolytic MEF or GLV-infected MEF were un- iquots of affected. From these results it can be
suggested that: (a) an "FMR-like" antigen
f MSV_ could be involved in PA as in classical
s detected CRT (Gomard et al., 1978) and (b) an
MSV-specific, or tumour-specific antigen
is certainly not concerned, since not only cell MSV tumour cells but also type C virus-
A infected but non-transformed cells can
ithASB function as targets in PA.
target A somewhat more surprising result was
cells§ found when anti-MSV and anti-FLV
effectorswere comparedinPAagainstMSV
4596 tumour cells. Whereas anti-FLV and anti-
16-1 MSVlymphocytes behave similarlyin CRT
° against MBL2 target cells (Table V), B6
anti-FLV were normally inactive in PA,
2195 or remained much less efficient than anti- 7.3 MSV lymphocytes. These results could be
o taken to suggest that the antigen recog-
;ht in test nized on MBL2 cells was lacking from the
surface of MSV-transformed cells. This by adding
h. a g hypothesis is, however, unlikely since:
ectors cells (a) the same anti-FLV lymphocytes were
h well. also inefficient against FLV-infected
adMethods mouse embryonic fibroblasts; (b) 6-days
6ys. in vitro coculture of anti-FLV lympho-
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TABLE IV.-Cytolytic activity (as % inhibitiont) ofanti-MSV spleen cells detected in PA
against MSB or type C virus-infected MEF
Target cellst
Spleen MSB Normal MEF MLV-infected FLV-infected R-MSV- GLV-infected
cells§ MEF MEF infected MEF MEF
Expt 1 46-7*** 0 36-6*** 21-2*** - 13-3 NS
Expt 2 34-6*** 57-2*** 51.0***
Expt 3 47.2*** - 33.1*** 35-8* 12-7* 12-6 NS
Expt 4 28.6*** 42.0*** - 17-5 NS
Expt 5 34-6*** 0 57-3*** 51.1***
t See Table I.
I See footnotes t and § of Table II.
§ Spleen cell: target cell ratio is 300:1 Target cells= 104.
TABLE V.-Comparison of cytolytic activity of anti-MSV and anti-FLV spleen cells
detected in PA and CRT
Activity in PA on MSB target cell
Effector: Effector:
target ratio 300:1 target ratio 200:1
Spleen-cell I, k_I_A_I -,
donors ct/mint Inhibition %t ct/min Inhibition %
Expt 1
Normal
Anti-MSV
Anti-FLV
Expt 2
Normal
Anti-MSV
Anti-FLV
Expt 3
Normal
Anti-MSV
Anti-FLV
B6
B6
B6
B6
B6
B6
B6
B6
B6
4259+860
2210+365
4747+689
4776±480
2552±559
3798± 689
5092± 704
3328± 559
5696± 836
48-1***
0
46-6***
20-4***
34.6***
0
3941± 893
3283± 872
3902±827
5447± 629
4481± 987
5026±510
4912±955
2452±494
4198±869
16-7***
0
17-7***
0
50-1***
14-5 NS
Activity in CRT on
MBL2 target cell
Effector:
target ratio 100:lt
51Cr release
61-2
64-3
45-5
47-5
31-3
31-7
t Optimal ratio-Similar activity found at 200:1 or 300:1.
1 See footnotes t, + and § of Table II.
cytes and MSV tumour cells resulted in a
strong secondary cytolytic activity against
MBL2 target cells (results not given).
Nature of the effector cells in PA
The cytolytic activity being specifically
abrogated by anti-Thy-1-2 and comple-
ment treatment of the effector cells, it
appeared dependent on the presence of T
lymphocytes (Table VI). Macrophages
were apparently not concerned, since
carbonyl iron and magnet treatments did
not significantly decrease attacker-cell
efficiency. The role of a non-phagocytic
but plastic-adherent cell cannot be ruled
out, since the activity of the whole-spleen
cell suspension was clearly decreased by
plastic adherence (Table VI) and still more
by plastic adherence plus carbonyl iron
treatment. It must benoted, however, that
after such treatments the activity of the
treated cells was always greater if
measured in a 48-h rather than in a 24-h
assay. This suggested that relatively
time-consuming and aggressive manipu-
lations could have non-specifically altered
the effector cells, which then need more
than 24 h to restore their normal func-
tions. This hypothesis was reinforced by
the fact that passing through nylon-wool
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TABLE VI.-Effect of different treatments on the activity of
in PA against MSB target cells
anti-MSV spleen cells tested
Spleen cells treated witht
Expt 1
Normal AKR Serum+C'
Anti-Thyl-2 Serum+C'
Normal AKR Serum+C'
Anti-Thyl-2 Serum+C'
ct/min
Incubation with normal
(h) lymphocytes$
24
24
48
48
Expt 2
Test medium
Carbonyl iron
Adherence on plastic
Carbonyl iron+adherence on plastic
Test medium
Carbonyl iron
Adherence on plastic
Carbonyl iron+adherence on plastic
Expt 3
Test medium
Passage through nylon-wool column
Test medium
Passage through nylon-wool column
t See Material and Methods.
t See footnotes t, t and § of Table II.
24
24
24
24
48
48
48
48
24
24
48
48
11451± 1981
10571 ± 1375
5197± 581
5883± 388
1331±
1617±
1683±
1428±
1097±
1025±
1271±
1143-'-
1115±
1392±
440±
494±
175
200
110
460
126
161
178
38
183
168
34
125
columns, which takes only a relatively
short time, did not decrease the cytolytic
activity of the spleen-cell suspensions. We
concluded, therefore, that the CTL were,
at least for the most part, the effector cells
ofthe anti-MSV reaction measured in PA.
The role of cytolytic T lymphocytes
(CTL) would be further supported by the
existence of an H-2 restriction of cytolytic
activity, this property being one of the
major characteristics of CTL in the MSV
(Gomard et al., 1976) as well as in many
other systems (Doherty et al., 1976;
Dennert 1976; Forman 1976; Shearer et
al., 1976). The experiments reported in
Table VII showed that such an H-2
restriction can be found in PA, allogeneic
MSV tumour cells being lysed significantly
but at a 2-3-times lower level than
syngeneic targets. However, we have never
found in PA, the very strong H-2 restric-
tion which is regularly detected in CRT
with lymphoma target cells (Gomard et al.,
1978).
The involvement ofH-2 normal antigens
in the effector-target-cell interaction is
clearly confirmed by the observation that
preincubation of H-2b tumour cells with
anti-H-2b antibodies specifically abro-
gated their sensitivity to syngeneic anti-
MSV effector cells in PA (Table VIII) as
previously shown in the CRT (Gomard et
al., 1977).
Detection ofnatural killer (NK) cells in PA
The cytolytic activities of non-immune
spleen cells were measured in PA by com-
paring cytolysis in the presence of normal
lymphoid cells and in medium alone. The
results in Table IX show that in PA
normal murine spleen cells had a strong
killer activity for: (a) normal mouse
fibroblasts; (b) type C virus-infected
murine cells whether transformed or
untransformed; (c) normal xenogeneic
cells. This NK-cell activity was not H-2
restricted, and did not depend on a viral
antigen, since it was also found with non-
virus-infected cells. It was not dependent
on tumour antigen(s) since normal cells
were also affected. It appeared, therefore,
as mainly non-specific and predominantly
determined by the general sensitivity of
the target cells to immune cytolysis, a
ct/min
with immune
lymphocytest
7935+1413
10685± 1818
2351± 463
5868± 1083
Inhibitiont
30.7***
0
54-7***
0
53-4***
51.2***
20-2***
3 9 NS
65-2***
46.3***
21-9***
13.3*
63.5***
55-7***
42-0***
41-3***
620±
789±
1343±
1371±
375±
550±
993±
991 ±
407±
617±
255±
290±
62
212
110
206
49
94
203
150
99
116
73
108
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TABLE VII.-Cytolysis of MSV-transformed cells by syngeneic or allogeneic effector cells
Spleen- Effector
cell H-2 Haplo- target
donors type ratio
Normal mice b/d§ 300
200
100
50
B6 anti-MSV b 300
200
100
50
BALB/c anti-MSV d 300
200
100
50
BlO.D2 anti-MSV d 300
200
100
50
BALB/B anti-MSV b 300
200
100
50
ct/min
4184±368
4537± 633
4777±422
4502±425
11544±276
1830±554
2426± 779
3775±497
2619±519
3042± 125
4389± 874
4101 ±239
1368±447
1697± 175
2800±411
3605± 720
2523±393
3255± 319
3531± 628
4197± 328
Target cells
MSB MSC
Inhibitiont Lytict Inhibitiont Lytict
units ct/min units
759± 156
840± 112
930± 79
1156± 40
72.4*** 300± 28 60-4***
59-6*** 9*9 373± 44 55.5*** 5-8
49.2*** 630±106 32-2***
16-1*** 857± 54 25-8***
37-4*** 409± 81 46-1***
32.9*** 1-6 471± 72 43-9*** 2-5
8-2 NS 686±146 26-2***
8-8 NS 877± 53 24-1***
67-3*** 306± 47 59-6***
62-5*** 7-4 364+ 59 56-6*** t6-6
41-3*** 401± 38 56-8***
19.9* 599± 129 48-1***
36-9*** 547± 69 27-9*
28-2*** 2-3 646±208 23-1* 0
26-1* 769+ 139 17-9*
6-7 NS 1066±149 7-8 NS
t See footnotes t, t and § of Table II.
$ See Material and Methods.
§ b with MSB targets and d with MSC targets.
TABLE VIII.-Effect of anti-H-2b serum on the activity in
cells
PA of H-2b anti-MSV spleen
Spleen cell: target cell ratio
300:1 200:1
I , A
I .
MSB Target cells
treated witht I
Expt 1
Test medium
Normal mouse serum
BALB/c anti-BALB/B
serum
ct/min with ct/minwith
normalt immunel
lymphocytes lymphocytes
6723± 782 5483±822
4282±597 3373±595
3801±654 3545±361
ct/min with ct/min with
inhibitiont normal immune
% lymphocytes lymphocytes
18-4***
21-2***
6-7 NS
Expt 2
Normal mouse serum 2167±360 784±372
BALB/c anti-BALB/B
serum 1428±382 1357±400
t See Material and Methods.
I See footnotes t, + and § of Table II.
clear parallelism existing, for example,
between the sensitivity to NK cells and
the sensitivity to related anti-H-2 lym-
phocytes. Table X shows that the effector
cells were non-phagocytic and non-T. It is
important to emphasize that aliquots of
the same effector-cell populations were
63.8*** 2250±293 1432±324 36-4***
4 9 NS 1842±474 1810±344 1-7 NS
always devoid of cytolytic activities when
tested in CRT against ascitic tumour cells
(results not given).
DISCUSSION
The above-reported results show that
PA is a convenient method of revealing
inhibitionl
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TABLE IX.-Spontaneous cytolytic activity of normal spleen cells in PA (Inhibition %)t
Spleen-cell
donors
Normal BALB/c
Normal CBA
Normal C3JH/He
Normal DBA/2
Normal Swiss
Normal B6
Normal AKR
B6 anti-BALB/c¶
B6 anti-AKRT
Target cellst
(a) Normal mouse cell lines
NZB (H-2d) Swiss (H-2S) BALB 3T3 (H-2d)
0 69-3*** 43.0***
0 68-5*** 78-1***
0 50 0*** 60-4***
0 74-9*** 73-8***
0 74-2*** 53-4***
NTII NT NT
0 70.4*** 64-8***
0 0 75-3***
0 0 NT
C3H (H-2k)
0
10-8 NS
8-0 NS
11-5 NS
0
NT
10 NS
0
0
(b) transformed and/or type C virus-producer cell lines
Normal B6
Normal BALB/c
Normal AKR
Normal CBA
Normal C3H/He
Normal DBA/2
Normal Swiss
BALB/c anti B6T
B6 anti BALB/c¶
Normal BALB/c
Normal C3H/He
Normal DBA/2
Normal Swiss
Normal B6
(c) Xenogeneic cell lines
SIRC (Rabbit) NRK (Rat) CCC S+L- (Cat)
0 48-5*** 83-3***
0 46-7*** 83-2***
0 36-5*** 56-5***
0 33-8*** 83-1***
0 33 0*** 81-1***
t See Table I.
I Inhibition percentage was calculated as follows:
100 X meanct/minafterincubationwith testmedium-meanct/minafterincubationwithnormallymphocytes
mean ct/min after incubation with test medium
11 NT=not tested.
T 50 x 106 normal spleen cells inoculated i.p. 4 days before.
specific cell-mediated cytolytic reactions
against MSV tumour cells. The cytolysis
induced by immune lymphocytes is pre-
dominantly, if not exclusively, due to T
cells. The possible involvement of a minor
population of plastic-adherent cells does
not change this conclusion, since its
activity was abrogated by an anti-Thy
1-2 and complement treatment, suggesting
that it too may be a T-cell subpopulation.
The cytolytic activity appears very specific
and probably directed against the same
"FMR-like" antigen which is recognized
by anti-MSV CTL in CRT (Gomard et al.,
1978).
Despite the use oftumour target cells in
monolayers and of relatively long in vitro
incubations, PA gives much more specific
results than MA. The fact that PA does
not measure cytostatic phenomena is
probably determinant (Seeger et al., 1974).
Moreover, according to the recent results
of Brooks et al. (1978) we may suppose
that the use of labelled amino acids in
place of radioactive nucleotides explains
its better specificity than that of other
isotopic MA. PA allows one to detect the
cytolysis of MSV tumour cells themselves,
whereas CRT fails to do so, or provides
only very weak and hardly reproducible
results. This advantage of PA contrasts
with its lower sensitivity than classical
SC-1 (H-2?)
61-2***
NT
75.0***
24.9***
29-1***
29-1***
NT
NT
NT
K-BALB/c
(H-2d)
37-3***
46-3***
NT
NT
NT
NT
NT
NT
NT
MLV-infected
K-BALB/c
(H-2d)
24-2***
40.9***
NT
NT
NT
NT
NT
NT
NT
MSB (H-2b)
NT
0
29-7***
48-4***
28-2***
45-8***
23-1***
78-4***
NT
MLV infected
C3H-MSV
(H-2k)
17-0***
16.6***
NT
NT
NT
NT
NT
NT
NT
MSV-85
(H-2d)
19.0***
23.9***
NT
NT
NT
NT
NT
NT
23-9***
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CRT using lymphoma cells as target. It is
probably related to the longer in vitro
incubations which are possible with PA,
allowing lysis of relatively insensitive
tumour cells. Such incubations are hardly
possible in CRT due to the high level of
spontaneous marker elution, except when
specially selected tumour cells are used.
Moreover, the cellular lesion which is
necessary to allow the detachment of
altered cells from the plastic could be an
earlier step in cell death than the release
of 5lCr-labelled large molecules. PA ap-
pears, therefore, as a useful test in tumour
immunology whentumour-cell populations
growing in monolayer have to be used.
Nevertheless, it must be emphasized
that in the MSV system, PA and CRT,
whichbothrevealaCTL-mediatedreaction
directed against an "FMR-like" antigen,
do not provide identical results. At least 3
major differences have been detected in
our experiments:
(1) A natural killer activity was regularly
found in PA but not in CRT. It has been
detected, however, by others with the
latter method (Bean et al., 1973; Oldham
et al., 1977). The discrepancy is probably
related to the variable sensitivity of
tumour cells to NK-cell-mediated
cytolysis, with an especially high sensi-
tivity ofin vitro tumour cells (Sendo et al.,
1975). The fact that PA measures the cells
unsticking could account for its specially
high ability to reveal natural killing since
it is well established that non-T-cells are
frequently responsible for such pheno-
mena, independent of target-cell cytolysis
(Golstein, 1970). The important point
is that the NK-cell-mediated reactions
could mask, in PA experiments much
more than in CRT, weak CTL-mediated
cytolysis.
(2) Anti FLV-effector cells were much less
efficient in PA than anti-MSV, whereas
both kinds of CTL behave alike in CRT.
Thereasonsforthissurprisingphenomenon
is unclear, and the role of different cell-
surface antigens appears unlikely, as dis-
cussed above. An explanation may per-
haps be found in the high degree of
adhesiveness of anti-FLV-CTL. It is
known that these cells can be retained by
nylon-wool columns (Leclerc & Gomard,
1972) and we observed that they were
much nmore adherent to target-cell mono-
layers than anti-MSV-CTL. Whatever its
origin, this phenomenon could alter the
CTL-tumour-cell interaction and it could
be responsible for false-negative reactions
suggesting an incorrect pattern of antigen
specificity.
(3) The H-2 restriction of CTL reactivity
was far weaker in PA than in CRT. This
could be related to quantitation problems,
since when strongly efficient CTL are
tested the H-2 restriction can only be
established by quantitative experiments
using several L/T ratios (Gomard et al.,
1978). Such experiments are hardly pos-
sible in PA since the cytotoxic activity
falls very rapidly with decreasing L/T
ratios. The NK-cell activity is also in-
creased by prolonged in vitro incubations.
This NK activity, which increases the
background cytolysis, can in turn mask
some of the specific cytolysis, especially
at low L/T ratios when syngeneic but not
allogeneic effector cells should be efficient
at a relatively weak level. PA, therefore,
appears a priori to be a bad method for
revealing H-2 restriction phenomena, and
this may explain the weakness of the H-2
restriction of viral mammary-tumour cell
cytolysis previously reported (Stutman,
1977). It is remarkable, in view of the
above considerations, that it was never-
theless possible to establish that H-2
antigens were involved in PA reactivity,
as in the CRT, as demonstrated by the
strong blocking activity of anti-H-2
antibodies.
In conclusion, PA can be a useful
method of testing CTL-mediated anti-
tumour or anti-viral immune reactions,
but several peculiarities of the test should
be borne in mind in order to avoid mis-
interpretation of the results. Once again,
it appears that the technical parameters
are especially determinant in the detection
of cellular anti-tumour reactions, as
recently emphasized by other investiga-
6162 Y. HENIN, E. GOMARD, S. GISSELBRECHT AND J. P. LEVY
tions in different systems (Chou-Chik Ting
et al., 1977a, b; Oldham et al., 1977;
Brooks et al., 1978).
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